{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T23:38:47Z","timestamp":1785368327192,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["epilepsybehavior.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.yebeh.2018.03.033","type":"journal-article","created":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T13:26:49Z","timestamp":1524749209000},"page":"207-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["Psychiatric comedication in patients with epilepsy"],"prefix":"10.1016","volume":"83","author":[{"given":"Magdalena","family":"Bosak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Cyranka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Dudek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kowalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Mo\u0142ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"S\u0142owik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2018.03.033_bb0005","author":"World Health Organization"},{"issue":"12","key":"10.1016\/j.yebeh.2018.03.033_bb0010","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/j.1528-1167.2007.01222.x","article-title":"Psychiatric comorbidity in epilepsy: a population-based analysis","volume":"48","author":"Tellez-Zenteno","year":"2007","journal-title":"Epilepsia"},{"issue":"6","key":"10.1016\/j.yebeh.2018.03.033_bb0015","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1111\/j.1528-1167.2012.03500.x","article-title":"Epilepsy and psychiatric comorbidity: a nationally representative population-based study","volume":"53","author":"Rai","year":"2012","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2018.03.033_bb0020","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1212\/01.WNL.0000103282.62353.85","article-title":"Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy","volume":"62","author":"Boylan","year":"2004","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2018.03.033_bb0025","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1006\/ebeh.2000.0030","article-title":"Depression in epilepsy: a common but often unrecognized comorbid malady","volume":"1","author":"Kanner","year":"2000","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2018.03.033_bb0030","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.yebeh.2013.06.031","article-title":"Pharmacological treatment of psychiatric comorbidity in patients with refractory epilepsy","volume":"29","author":"Karouni","year":"2013","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.yebeh.2016.03.022","article-title":"Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: a review of the evidence","volume":"61","author":"Kanner","year":"2016","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0040","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-0404.2010.01370.x","article-title":"Psychiatric comorbidity and use of psychotropic drugs in epilepsy patients","volume":"190","author":"Henning","year":"2010","journal-title":"Acta Neurol Scand Suppl"},{"issue":"6","key":"10.1016\/j.yebeh.2018.03.033_bb0045","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1586\/14737175.4.6.953","article-title":"Use of psychotropic drugs in patients with epilepsy: interactions and seizure risk","volume":"4","author":"Mula","year":"2004","journal-title":"Expert Rev Neurother"},{"issue":"11","key":"10.1016\/j.yebeh.2018.03.033_bb0050","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s00228-010-0861-y","article-title":"Psychiatric comorbidity in patients with epilepsy: a population-based study","volume":"66","author":"Karouni","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.yebeh.2018.03.033_bb0055","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE official report: a practical clinical definition of epilepsy","volume":"55","author":"Fisher","year":"2014","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.yebeh.2018.03.033_bb0060","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0070","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.phrs.2016.02.014","article-title":"Clinically significant pharmacokinetic drug interactions of antiepileptic drugs with new antidepressants and new antipsychotics","volume":"106","author":"Spina","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.yebeh.2016.01.029","article-title":"Proconvulsant effects of antidepressants \u2014 what is the current evidence?","volume":"61","author":"Johannessen Landmark","year":"2016","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2018.03.033_bb0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2165\/00002018-200225020-00004","article-title":"Effects of psychotropic drugs on seizure threshold","volume":"25","author":"Pisani","year":"2002","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.yebeh.2018.03.033_bb0085","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.seizure.2011.06.015","article-title":"Use and costs of concomitant medicines in epileptic patients in Poland: a 12-month prospective multicentre study","volume":"20","author":"Majkowska-Zwoli\u0144ska","year":"2011","journal-title":"Seizure"},{"issue":"2","key":"10.1016\/j.yebeh.2018.03.033_bb0090","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1176\/jnp.17.2.172","article-title":"Clinical assessment of Axis I psychiatric morbidity in chronic epilepsy: a multicenter investigation","volume":"17","author":"Jones","year":"2005","journal-title":"J Neuropsychiatry Clin Neurosci"},{"issue":"12","key":"10.1016\/j.yebeh.2018.03.033_bb0095","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.0013-9580.2004.17504.x","article-title":"The epidemiology of the comorbidity of epilepsy in the general population","volume":"45","author":"Gaitatzis","year":"2004","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2018.03.033_bb0100","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.pjnns.2015.01.008","article-title":"Subtypes of interictal depressive disorders according to ICD-10 in patients with epilepsy","volume":"49","author":"Bosak","year":"2015","journal-title":"Neurol Neurochir Pol"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0105","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1528-1167.2008.01803.x","article-title":"The association between depression and epilepsy in a nationally representative sample","volume":"50","author":"Fuller-Thomson","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0110","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/ane.12191","article-title":"Clinical risk factors for depressive symptoms in patients with epilepsy","volume":"129","author":"Peng","year":"2014","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.yebeh.2018.03.033_bb0115","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jpsychores.2008.03.002","article-title":"Somatic and psychiatric comorbidity in the general elderly population: results from the ZARADEMP project","volume":"65","author":"Lobo-Escolar","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0120","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jad.2017.06.009","article-title":"Multimorbidity and depression: a systematic review and meta-analysis","volume":"221","author":"Read","year":"2017","journal-title":"J Affect Disord"},{"issue":"1\u20133","key":"10.1016\/j.yebeh.2018.03.033_bb0125","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.jad.2007.01.015","article-title":"Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys","volume":"103","author":"Scott","year":"2007","journal-title":"J Affect Disord"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2018.03.033_bb0130","first-page":"S15","article-title":"Evolution and management of Lennox\u2013Gastaut syndrome through adolescence and into adulthood: are seizures always the primary issue?","volume":"13","author":"Kerr","year":"2011","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0135","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.yebeh.2010.08.029","article-title":"Depression in epilepsy is associated with lack of seizure control","volume":"19","author":"Dias","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0140","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/j.1528-1167.2006.00612.x","article-title":"Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 Healthstyles Survey","volume":"47","author":"Kobau","year":"2006","journal-title":"Epilepsia"},{"issue":"11","key":"10.1016\/j.yebeh.2018.03.033_bb0145","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.wnl.0000247045.85646.c0","article-title":"Psychotropic effects of antiepileptic drugs","volume":"67","author":"Ettinger","year":"2006","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2018.03.033_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1684\/epd.2007.0063","article-title":"Depression in epilepsy: phenomenology, diagnosis and management","volume":"9","author":"Seethalakshmi","year":"2007","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0155","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.yebeh.2014.03.003","article-title":"Screening for depression in people with epilepsy: comparative study among neurological disorders depression inventory for epilepsy (NDDI-E), hospital anxiety and depression scale depression subscale (HADS-D), and Beck depression inventory (BDI)","volume":"34","author":"de Oliveira","year":"2014","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.yebeh.2018.03.033_bb0160","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00228-016-2092-3","article-title":"Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders \u2014 a pharmacoepidemiological study and clinical implications","volume":"72","author":"Baftiu","year":"2016","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.yebeh.2018.03.033_bb0165","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.eplepsyres.2017.11.001","article-title":"Utilisation and polypharmacy aspects of antiepileptic drugs in elderly versus younger patients with epilepsy: a pharmacoepidemiological study of CNS-active drugs in Norway, 2004\u20132015","volume":"139","author":"Baftiu","year":"2018","journal-title":"Epilepsy Res"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018302087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505018302087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T09:41:15Z","timestamp":1720258875000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505018302087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"alternative-id":["S1525505018302087"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.033","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychiatric comedication in patients with epilepsy","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2018.03.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}